NOONTALK MEDIA LIMITED (SEJ)
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: DISCLOSURE IN INTEREST OF DIRECTOR - WEE KENG NEO LYNDA
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: DISCLOSURE IN INTEREST OF DIRECTOR - WEE KENG NEO LYNDA
Ocugen to Participate in Upcoming August Investor Conferences
Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026
GCL Announces Fiscal Year 2026 Financial Results
T. ROWE PRICE GROUP REPORTS SECOND QUARTER 2026 RESULTS
American Tungsten Corp. Begins Trading on OTCQX Best Market
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
Enbridge Reports Strong Second Quarter Results, Reaffirms 2026 Guidance and Grows Secured Backlog to $41B